The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 6 March 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 243K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, M.
Right arrow Articles by Gabel, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, M.
Right arrow Articles by Gabel, C. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/3/859/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 5, March 6, 2000 859-870


Original Article

Deficiency of the Stress Kinase p38{alpha} Results in Embryonic Lethality: Characterization of the Kinase Dependence of Stress Responses of Enzyme-deficient Embryonic Stem Cells

Melanie Allenb, Linne Svenssona, Marsha Roachb, John Hamborb, John McNeishb, and Christopher A. Gabela
a Department of Respiratory, Allergy, Immunology, Inflammation, and Infectious Diseases
b Department of Genetic Technologies, Pfizer Central Research, Groton, Connecticut 06340

Correspondence to: Christopher A. Gabel, Department of Respiratory, Allergy, Immunology, Inflammation, and Infectious Diseases, Central Research, Pfizer, Inc., Groton, CT 06340. Tel:860-441-5483 Fax:860-715-2467 E-mail:christopher_a_gabel{at}groton.pfizer.com.

Released online: 6 March 2000

The mitogen-activated protein (MAP) kinase p38 is a key component of stress response pathways and the target of cytokine-suppressing antiinflammatory drugs (CSAIDs). A genetic approach was employed to inactivate the gene encoding one p38 isoform, p38{alpha}. Mice null for the p38{alpha} allele die during embryonic development. p38{alpha}1/- embryonic stem (ES) cells grown in the presence of high neomycin concentrations demonstrated conversion of the wild-type allele to a targeted allele. p38{alpha}-/- ES cells lacked p38{alpha} protein and failed to activate MAP kinase–activated protein (MAPKAP) kinase 2 in response to chemical stress inducers. In contrast, p38{alpha}1/+ ES cells and primary embryonic fibroblasts responded to stress stimuli and phosphorylated p38{alpha}, and activated MAPKAP kinase 2. After in vitro differentiation, both wild-type and p38{alpha}-/- ES cells yielded cells that expressed the interleukin 1 receptor (IL-1R). p38{alpha}1/+ but not p38{alpha}-/- IL-1R–positive cells responded to IL-1 activation to produce IL-6. Comparison of chemical-induced apoptosis processes revealed no significant difference between the p38{alpha}1/+ and p38{alpha}-/- ES cells. Therefore, these studies demonstrate that p38{alpha} is a major upstream activator of MAPKAP kinase 2 and a key component of the IL-1 signaling pathway. However, p38{alpha} does not serve an indispensable role in apoptosis.

Key Words: inflammation, cytokines, mitogen-activated protein kinase, signaling, cytokine-suppressing antiinflammatory drug


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS